Weitz G, Driessen M, Brouwer-Kelder E M, Sandhoff K, Barranger J A, Tager J M, Schram A W
Biochim Biophys Acta. 1985 Jan 28;838(1):92-7. doi: 10.1016/0304-4165(85)90254-5.
A soluble form of lysosomal sphingomyelinase was partially purified from human urine using concanavalin A-Sepharose 4B, Sephadex G-100 and octyl-Sepharose 4B chromatography. The octyl-Sepharose 4B eluate was used to immunise a rabbit. The antiserum obtained was able to precipitate about 70% of the sphingomyelinase activity present in urine from control subjects. Both the immunoprecipitable and non-precipitable activities were found to be deficient in urine from patients with Niemann-Pick disease Type A and Type B. In contrast, both activities were present in urine from patients with Niemann-Pick disease Type C. The antiserum was able to precipitate about 80% of the sphingomyelinase activity present in an aqueous extract of placenta.
利用伴刀豆球蛋白A-琼脂糖4B、葡聚糖凝胶G-100和辛基琼脂糖4B层析从人尿中部分纯化出一种可溶性溶酶体鞘磷脂酶。用辛基琼脂糖4B洗脱液免疫一只兔子。获得的抗血清能够沉淀对照受试者尿液中约70%的鞘磷脂酶活性。在A型和B型尼曼-匹克病患者的尿液中,免疫沉淀活性和非沉淀活性均缺乏。相比之下,C型尼曼-匹克病患者的尿液中这两种活性都存在。该抗血清能够沉淀胎盘水提取物中约80%的鞘磷脂酶活性。